Investigational Drug Services, The George Washington University Medical Center is a clinical research site located in Washington D.C., District of Columbia, United States 20037.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
Investigational Drug Services, The George Washington University Medical Center has participated in 1 clinical trials.
Therapeutic areas: Neuropathic Pain.
Sponsors: Pfizer's Upjohn has merged with Mylan to form Viatris Inc..
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Investigational Drug Services, The George Washington University Medical Center has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Investigational Drug Services, The George Washington University Medical Center has 1 clinical trials on record. Their work covers Neuropathic Pain.
Investigational Drug Services, The George Washington University Medical Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.